SMC unable to recommend prednisone (Lodotra™) for the treatment of moderate to severe, active rheumatoid arthritis due to non-submission

Source: Scottish Medicines Consortium (SMC)

Date published: 14/02/2012 17:38

Summary
by: Sheetal Ladva

The Scottish Medicines Consortium (SMC) is unable to recommend the use of prednisone (Lodotra™) within NHS Scotland for the treatment of moderate to severe, active rheumatoid arthritis particularly when accompanied by morning stiffness.

 
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. 

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.